Home News Screener Backtests

Compare Stocks Dividend Calculator Options Calculator NYSE Holidays NASDAQ Holidays Earnings Calendar Widgets

US Dividend Stocks Monthly Dividend Stocks Annual Dividend Stocks Quarterly Dividend Stocks Semi-Annual Dividend Stocks

Best Penny Stocks Undervalued Stocks New Stocks Uptrend Stocks Uptrend Penny Stocks

Blue Chip Stocks With High Dividends Blue Chip Under $10 Blue Chip Under $20 Blue Chip Under $50 Undervalued Blue Chip Stocks

Best Small Cap Best Micro Cap Best Mid Cap Best Large Cap

Oil Stocks Energy Stocks Technology Stocks AI Stocks Pharma Stocks Financial Stocks

Under $200 Under $100 Under $50 Under $20 Under $10 Under $5 Under $1

Best 52 Week Low Best 52 Week Nasdaq Low Best 52 Week NYSE Low Best 52 Week Low Penny Best 52 Week Low Blue Chip Best 52 Week High Best 52 Week Nasdaq High Best 52 Week NYSE High Best 52 Week High Penny

Best Nasdaq Stocks Best NYSE Stocks

Insider Buying Insider Selling

MACD Crossed Above Signal Line MACD Crossed Above Zero RSI Above 90 RSI Above 80 RSI Above 70 RSI Above 50 RSI Below 50 RSI Below 30 RSI Below 20 RSI Below 10

Tech Stocks with Low PE PE Ratio Less Than 1 PE Ratio Less Than 10 PE Ratio Less Than 15 US stocks With Low PE Low PE & High Dividends Low PE & High EPS Large Cap & Lowest PE

Books Trading Platforms Blog Forum

Sign In Sign Up

Home
- Sign In
- Sign Up
News
Screener
Backtests
- Books
Trading Platforms
Blog
Forum

Search Ticker

Home
KLRS
KLRS News

Latest Kalaris Therapeutics Inc. Common Stock (KLRS) News on March 29, 2025

Share on Social Networks:

Home
Screener
Contact us
Privacy Policy
Terms of Use

© FinQuota. 2025. All rights reserved.